Hepatic Vascular Shunts Mimicking Malignant Lesions on 18F-FDG PET/CT Imaging: Interpretation Pitfall in the Background of Cirrhotic Liver
PDF
Cite
Share
Request
Interesting Image
VOLUME: 35 ISSUE: 1
P: 61 - 63
February 2026

Hepatic Vascular Shunts Mimicking Malignant Lesions on 18F-FDG PET/CT Imaging: Interpretation Pitfall in the Background of Cirrhotic Liver

Mol Imaging Radionucl Ther 2026;35(1):61-63
1. University of Iowa Health Care Faculty of Medicine Department of Radiology, Division of Nuclear Medicine, Iowa City, United States
No information available.
No information available
Received Date: 16.02.2025
Accepted Date: 21.09.2025
Online Date: 03.02.2026
Publish Date: 03.02.2026
PDF
Cite
Share
Request

Abstract

A 44-year-old female presented with recent history of ischemic strokes and hypercoagulability and chronic alcoholic cirrhosis. 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography was performed during the workup for vasculitis. PET features of vasculitis were not identified, but liver showed multiple hepatic FDG avid foci, concerning for malignant or metastatic disease in the background of cirrhosis of liver. To characterize these lesions, liver magnetic resonance imaging was subsequently performed which revealed hepatic vascular shunts corresponding to the sites of the FDG avid foci. This case highlights potential interpretation n pitfall arising due to FDG avidity in the vascular shunts resembling malignant or metastatic lesions.

Keywords:
18F-FDG PET/CT, hepatic vascular shunt, liver cirrhosis

Ethics

Informed Consent: Requirement for informed consent was waived by University of Iowa’s Human Subject Office.

Authorship Contributions

Concept: P.M., M.G., A.S., Design: A.S., Data Collection or Processing: S.J., A.S.E., Analysis or Interpretation: P.M., M.G., A.S., Literature Search: S.J., A.S.E., Writing: S.J., A.S.E.
Conflict of Interest: No conflicts of interest were declared by the authors.
Financial Disclosure: The authors declare that this study has received no financial support.

References

1
Lebech AM, Gaardsting A, Loft A, Graff J, Markova E, Bertelsen AK, Madsen JL, Andersen KF, Benzon EV, Helms M, Mathiesen LR, David KP, Kronborg G, Kjaer A. Whole-body 18F-FDG PET/CT is superior to CT as first-line diagnostic imaging in patients referred with serious nonspecific symptoms or signs of cancer: a randomized prospective study of 200 patients. J Nucl Med. 2017;58:1058-1064.
2
Slart RHJA; Writing group; Reviewer group; Members of EANM cardiovascular; members of EANM Infection & Inflammation; Members of Committees, SNMMI Cardiovascular; Members of Council, PET Interest Group; Members of ASNC; EANM Committee Coordinator. FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC. Eur J Nucl Med Mol Imaging. 2018;45:1250-1269.
3
Wang Q, Koniaris LG, Milgrom DP, Patel A, Hu M, Cui E, Deng Y, Akisik F. CT and MRI imaging and interpretation of hepatic arterioportal shunts. Transl Gastroenterol Hepatol. 2019;4:34.
4
Ozaki K, Harada K, Terayama N, Kosaka N, Kimura H, Gabata T. FDG-PET/CT imaging findings of hepatic tumors and tumor-like lesions based on molecular background. Jpn J Radiol. 2020;38:697-718.
5
Tan GJ, Berlangieri SU, Lee ST, Scott AM. FDG PET/CT in the liver: lesions mimicking malignancies. Abdom Imaging. 2014;39:187-195.
6
Coenegrachts K. Magnetic resonance imaging of the liver: new imaging strategies for evaluating focal liver lesions. World J Radiol. 2009;1:72-85.
7
Bashir U, Shah S, Jeph S, O’Keeffe M, Khosa F. Magnetic resonance (MR) imaging of vascular malformations. Pol J Radiol. 2017;82:731-741.
8
Flors L, Leiva-Salinas C, Maged IM, Norton PT, Matsumoto AH, Angle JF, Hugo Bonatti M, Park AW, Ahmad EA, Bozlar U, Housseini AM, Huerta TE, Hagspiel KD. MR imaging of soft-tissue vascular malformations: diagnosis, classification, and therapy follow-up. Radiographics. 2011;31:1321-1340.